Autosomal dominant childhood-onset proximal spinal muscular atrophy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:363447OMIM:158600G12.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal dominant childhood-onset proximal spinal muscular atrophy is a rare genetic condition that affects the nerve cells in the spinal cord responsible for controlling muscles, known as motor neurons. Unlike the more commonly known forms of spinal muscular atrophy (SMA) caused by changes in the SMN1 gene, this form follows an autosomal dominant inheritance pattern, meaning only one copy of the altered gene is needed to cause the disease. It typically begins during childhood and primarily affects the muscles closest to the center of the body (proximal muscles), such as those in the hips, thighs, shoulders, and upper arms. Children with this condition usually develop progressive muscle weakness that makes activities like climbing stairs, running, standing up from a seated position, and lifting their arms increasingly difficult over time. The weakness tends to be symmetrical, affecting both sides of the body similarly. Some individuals may also experience muscle wasting (atrophy) and reduced or absent deep tendon reflexes. The severity and rate of progression can vary between affected individuals, even within the same family. There is currently no cure for this condition. Treatment focuses on managing symptoms and maintaining function for as long as possible. This typically involves physical therapy, occupational therapy, orthopedic interventions, and assistive devices. The newer SMA therapies approved for SMN1-related SMA (such as nusinersen, onasemnogene abeparvovec, and risdiplam) are not applicable to this form since it involves a different genetic cause. Research into the specific genetic mechanisms continues, and affected families are encouraged to work closely with a team of specialists.

Also known as:

Key symptoms:

Weakness in muscles close to the body (hips, shoulders, thighs, upper arms)Difficulty climbing stairsTrouble standing up from a sitting or lying positionDifficulty running or keeping up with peersMuscle wasting or thinning, especially in the legs and armsReduced or absent reflexesWaddling gait or unusual walking patternDifficulty lifting arms above the headFatigue during physical activitiesPossible mild tremor in the fingers (fasciculations)Progressive loss of muscle strength over timePossible development of scoliosis (curved spine)

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal dominant childhood-onset proximal spinal muscular atrophy.

View clinical trials →

No actively recruiting trials found for Autosomal dominant childhood-onset proximal spinal muscular atrophy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal dominant childhood-onset proximal spinal muscular atrophy community →

No specialists are currently listed for Autosomal dominant childhood-onset proximal spinal muscular atrophy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal dominant childhood-onset proximal spinal muscular atrophy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal dominant childhood-onset proximal spinal muscular atrophyForum →

No community posts yet. Be the first to share your experience with Autosomal dominant childhood-onset proximal spinal muscular atrophy.

Start the conversation →

Latest news about Autosomal dominant childhood-onset proximal spinal muscular atrophy

No recent news articles for Autosomal dominant childhood-onset proximal spinal muscular atrophy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific genetic test was used to confirm this diagnosis, and is further testing recommended for our family?,How quickly is this condition likely to progress in my child's case?,What physical therapy and exercise programs are recommended to maintain strength?,Are there any clinical trials or research studies we should know about?,When should we start monitoring breathing function, and how often?,What school accommodations should we request for my child?,Should other family members be tested for this genetic change?

Common questions about Autosomal dominant childhood-onset proximal spinal muscular atrophy

What is Autosomal dominant childhood-onset proximal spinal muscular atrophy?

Autosomal dominant childhood-onset proximal spinal muscular atrophy is a rare genetic condition that affects the nerve cells in the spinal cord responsible for controlling muscles, known as motor neurons. Unlike the more commonly known forms of spinal muscular atrophy (SMA) caused by changes in the SMN1 gene, this form follows an autosomal dominant inheritance pattern, meaning only one copy of the altered gene is needed to cause the disease. It typically begins during childhood and primarily affects the muscles closest to the center of the body (proximal muscles), such as those in the hips, th

How is Autosomal dominant childhood-onset proximal spinal muscular atrophy inherited?

Autosomal dominant childhood-onset proximal spinal muscular atrophy follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Autosomal dominant childhood-onset proximal spinal muscular atrophy typically begin?

Typical onset of Autosomal dominant childhood-onset proximal spinal muscular atrophy is childhood. Age of onset can vary across affected individuals.